Abarceo Pharma
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Park Per Albin Hanssons Vä 41, Malmoe, S...Website
www.abarceo.comRevenue
<$5 MillionIndustry
About Abarceo Pharma
Is Abarceo Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Abarceo Pharma is spiking on competitors!
Product Launch: Get notified when Abarceo Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Abarceo Pharma
Earning: See what the market has to say on Abarceo Pharma recently announced quarterly report
Click to see if Abarceo Pharma had a recent Job posting/layoffs
Abarceo Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Abarceo Pharma has new funding data
Website visits: Recent activity has been detected on your website
Check if Abarceo Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Abarceo Pharma as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Abarceo Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Abarceo Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Abarceo Pharma.
Abarceo Pharma Tech Stack
A closer look at the technologies used by Abarceo Pharma
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abarceo Pharma
Abarceo Pharma is a pre-clinical stage company focused on restoring mitochondrial health, particularly in Type 2 Diabetes (T2D) and other age-related diseases. Founded in 2017 by renowned scientists from Lund University, the company has identified a novel target, VDAC1, which plays a crucial role in beta cell function and energy production. Abarceo... Read More